Liquid Biopsy Platform

LifeOS Genomics Corporation

Hsinchu City, Taiwan

LifeOS Genomics Corporation is an innovative biotechnology company based in Hsinchu Science Park, Taiwan. LifeOS Genomics is dedicated to the development and commercialization of cutting-edge automated genetic testing instruments and assay reagents that enable routine genetic testing in hospitals and distributed test laboratories. The company is ISO13485:2016 certified and in full compliance with FDA Quality System Regulation (QSR). Bridging the Gap Between PCR and NGS QLoci md1000 Dx Analyzer is based on LifeOS Genomics proprietary Multiplex Digital PCR (mdPCR) technology. It brings about a significant advancement in genetic testing that bridges the gap between research and clinical utility, by providing a platform that can be used for seamlessly translating biomarkers from research into clinical practice. The QLoci md1000 Dx Analyzer provides unique features that open up new possibilities for clinical molecular testing market. Addressing Unmet Needs in Liquid Biopsy The QLoci md1000 Dx Analyzer fills a critical gap between traditional PCR and Next-Generation Sequencing (NGS) by offering unmatched capabilities of addressing unmet needs in liquid biopsy in research and clinical diagnosis. With its unmatched sensitivity and accuracy for clinically relevant biomarkers , our fully automated sample-to-report workflow simplifies the decision-making of medical professionals and researchers in their daily work.